<div>Intermediate Capital Group Plc has hired a five-member team to invest in biotechnology companies, according to an emailed company statement, reported Bloomberg. The team will be led by Allan Marchington <a target="_blank" href="https://www.linkedin.com/in/allanmarchington/">(LinkedIn)</a>, who will become Managing Director and head of ICG Life Sciences, said the statement. Also joining are Toby Sykes, Simon Tate, Peter Kiener and Tracy Weightman. The team all previously worked together at Bridge Valley Ventures. Team will be based in London and Boston, and will focus on making equity investments in companies in the U.K., Europe and North America</div>

Intermediate Capital Group

Wealth & Asset Mgmt

Private Equity

Intermediate Capital Group | Team Move | ICG Life Sciences | Americas | EMEA

Hire

Finance

Credit

Head of US Liquid Credit, US

ICG, the global alternative asset manager, today announced the appointment of Caterina Ket to its Marketing and Client Relations team, based in Frankfurt. Caterina will work alongside ICGs existing local team to support fundraising across the DACH region. Caterina joins ICG with fifteen years of experience servicing clients within the investment management space. Most recently, she served as Institutional Client Director at Mercer, responsible for developing its non-pension client base in Germany and covering the full investment spectrum. Prior to Mercer, Caterina spent over a decade at Schroders, as a senior sales manager and ESG specialist for sustainable investment solutions. Her prior experience also includes several years as a relationship manager in private banking at ABN AMRO Singapore. We are delighted to welcome Caterina to the team. Her hire reflects ICGs ongoing commitment to building out its client coverage in the DACH region, while her ESG experience and consultant background is well-suited to our focus on sustainable investment practices. ICG has a proven track record managing client capital, and I look forward to working with Bastian and the wider team to service existing clients and win new accounts, as the firm continues to grow. ICG provides flexible capital solutions to help companies develop and grow. We are a leading global alternative asset manager with over 30 years history, managing $81bn of assets and investing across the capital structure. We operate across four asset classes: Structured and Private Equity, Private Debt, Real Assets, and Credit. We develop long-term relationships with our business partners to deliver value for shareholders, clients, and employees, and use our position of influence to benefit the environment and society. We are committed to being a net zero asset manager across our operations and relevant investments by 2040.

Caterina Ket Joins ICGs Marketing Team in Frankfurt for Growth

Operations

Marketing

Associate Director, Fund Marketing

Stelios Elia joins ICG’s European Corporate Strategy as Managing Director
"Stelios brings an impressive track-record, particularly within the TMT sector, which will help to further strengthen our flagship strategy," says David Lomer, Head of UK, Nordics & Benelux for European Corporate. ICG, the global alternative asset manager, today announced the appointment of Stelios Elia as a Managing Director within its European Corporate team. Based in London, Stelios will focus on identifying and pursuing opportunities in the UK, Nordics and Benelux, whilst also bolstering the teams Telecoms, Media and Technology (TMT) coverage. Stelios joins ICG following a highly successful 15-year tenure with BC Partners, where he served as a Managing Director in their European Private Equity team. During this period, he originated and executed a number of notable investments within the TMT sector, including the acquisition of United Group, Acuris, Pharmathen, and Keesing. Prior to this, Stelios worked at McKinsey & Company, where he focussed primarily on strategy, private equity, and hedge fund related projects. European Corporate is one of ICGs flagship strategies with a 33-year track record, having invested â¬29bn since inception, offering flexible and tailored solutions for investors. The team comprises 31 investment professionals located across Europe. We are excited to welcome an investor of Stelios calibre to ICG. He brings an impressive track-record, particularly within the TMT sector, which will help to further strengthen our flagship strategy and drive growth in our key target markets of the UK, Nordics and Benelux. I am delighted to be joining at such an exciting time for ICG. The firm boasts an excellent track record, a strong positive momentum, and a compelling investment proposition. I look forward to collaborating with the team to support the firms next phase of growth. ICG provides flexible capital solutions to help companies develop and grow. We are a leading global alternative asset manager with over 30 years history, managing 81bn of assets and investing across the capital structure. We operate across four asset classes: Structured and Private Equity, Private Debt, Real Assets, and Credit. We develop long-term relationships with our business partners to deliver value for shareholders, clients, and employees, and use our position of influence to benefit the environment and society. We are committed to being a net zero asset manager across our operations and relevant investments by 2040. ICG is listed on the London Stock Exchange (ticker symbol: ICP). Further details are available at www.icgam.com. You can follow ICG on LinkedIn, X (Twitter) and Instagram.

Stelios Elia Joins ICGs European Corporate Strategy as Managing Director

Services

Managing Director (MD)

Intermediate Capital Group | Team Move | ICG Life Sciences | Americas | EMEA

latest related moves